Indian Pharmaceutical Alliance

The biologics space is moving fast and India is firmly in the race. In 2 days, IPA × CPI brings together industry leaders to navigate the future of Biologics & mRNA. From cutting-edge science to the policies shaping our ecosystem, this is a conversation worth showing up for. 🗓️ 27 March 2026 | 🕓 16:00 IST | 💻 Virtual | Free to attend Save your spot now: tinyurl.com/32kudtwm @ukCPI | Abbott India | @AjantaPharmaLtd | @Alkem_Lab | @Alembic_Pharma | @AurobindoGlobal | @Cadila_Pharma | @Cipla_Global | @drreddys | @EmcurePharma | Glenmark | Intas | Ipca Laboratories | @LupinGlobal | Macleods Pharma | @Pharma_Mankind | Micro Labs Limited | @pharma_natco | @PanaceaBiotec | @PiramalPharma | @SunPharma_Live | @TorrentPharmaIn | USV Limited | @ZydusUniverse #Biologics #mRNA #Biopharma #Innovation #Webinar #LifeSciences #IPA #IndianPharma

In 1952, India launched one of the world's first national TB programmes. The disease felt permanent. Unbeatable. Seven decades later, the data tells a different story. India has cut TB incidence by 21% since 2015, nearly double the global rate of decline. Progress like this doesn't happen without affordable, reliable medicines reaching patients at scale. That has always been and remains the commitment of India's pharmaceutical industry. The Indian Pharmaceutical Alliance recognises all those working steadily toward a TB-free India. #WorldTBDay2026 #IPA #IndiaPharma #EndTB #TBMuktBharat

The Indo-American Chamber of Commerce (IACC) invites you to an insightful webinar on “India–US Pharmaceutical Partnership: Innovation, Regulation & Market Opportunities” coming Wednesday, 25th March 2026 from 7:00 PM to 8:30 PM IST on Zoom. Join industry leaders and experts as they explore the evolving landscape of pharma collaboration between India and the US, covering innovation, regulatory frameworks, and emerging market opportunities. The webinar will feature distinguished speakers from global healthcare and pharmaceutical sectors. So, don’t miss this opportunity to gain strategic insights and connect with key stakeholders shaping the future of the pharma industry. Register now: us02web.zoom.us/webinar/regist… #IACC #PharmaIndustry #IndiaUSRelations #HealthcareInnovation #Pharmaceuticals #LifeSciences #GlobalHealthcare #PharmaLeaders #BusinessWebinar #Innovation #RegulatoryAffairs #MarketOpportunities #HealthcareLeaders #CrossBorderBusiness #IndiaBusiness #USIndia #PharmaGrowth #HealthcareTrends #Networking #IndustryExperts #VirtualEvent #ZoomWebinar #BusinessInsights #HealthcareSector @NewJerseyEDA @IPAOfficialPage @AjantaPharmaLtd @Arc1307 @iaccpresident @NehalDesai2909 @ATT

With just 3 days to go, the conversation shaping the future of biologics and mRNA is almost here. As India stands at the cusp of a major biopharma opportunity, the focus now shifts to building scale, advancing capabilities, and unlocking global leadership. Join IPA and CPI as leading experts come together to discuss what it will take to navigate this next phase of growth. 🗓️27 March 2026 | 🕓 16:00 IST | 💻Virtual | Free to attend Save your spot now: tinyurl.com/32kudtwm @ukCPI | Abbott India | @AjantaPharmaLtd | @Alkem_Lab | @Alembic_Pharma | @AurobindoGlobal | @Cadila_Pharma | @Cipla_Global | @drreddys | @EmcurePharma | Glenmark | Intas | Ipca Laboratories | @LupinGlobal | Macleods Pharma | @Pharma_Mankind | Micro Labs Limited | @pharma_natco | @PanaceaBiotec | @PiramalPharma | @SunPharma_Live | @TorrentPharmaIn | USV Limited | @ZydusUniverse #Biologics #mRNA #Biopharma #Innovation #Webinar #LifeSciences #IPA #IndianPharma

𝗣𝗹𝗲𝗮𝘀𝗲 𝗻𝗼𝘁𝗲: 𝗧𝗵𝗲 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝘁𝗶𝗺𝗲 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝗿𝗲𝘃𝗶𝘀𝗲𝗱 𝘁𝗼 𝟭𝟲:𝟬𝟬 𝗜𝗦𝗧. 39+ high-value biologic patents are set to expire by 2032, and the biosimilar opportunity they unlock could redefine Indian pharma's global standing. But seizing this opportunity requires more than ambition. It calls for world-class manufacturing capabilities, advanced expertise in biologics and mRNA, and strong collaborative partnerships. Join IPA and CPI to explore the pathways shaping the future of biomanufacturing. 📅 27 March 2026 | 🕒 16:00 IST | 💻 Virtual | Free to attend 🔗 Register here: tinyurl.com/32kudtwm @ukCPI #Biologics #mRNA #Biopharma #Innovation #Webinar #LifeSciences #IPA #IndianPharma

The conversation shaping India's biologics future is happening on 27 March, and these are the minds leading it. Biologics and mRNA are redefining what's possible for Indian pharma. But seizing this opportunity demands deep expertise, robust manufacturing capability, and the right partnerships. Join Dr Shridhar Narayanan in conversation with Dr Helen Young, Dr Clare Trippett, and Dr Arun Harish as they unpack: → What it takes to build world-class biologics manufacturing capability → How mRNA is opening new frontiers in therapeutics → The collaboration models that can fast-track India's biopharma ambitions This is a free, one-hour session you won't want to miss. 📅 27 March 2026 | 🕒 15:00 IST | 💻 Virtual 🔗 Register now: tinyurl.com/32kudtwm @ukCPI #Biologics #mRNA #Biopharma #Innovation #Webinar #LifeSciences #IPA #IndianPharma

From India to the world, his science reshaped modern medicine. Through groundbreaking drug discoveries in the 1930s and ’40s, Yellapragada Subbarow left an enduring mark on global pharmaceutical research, one that continues to influence healthcare innovation decades later. Discover the India Pharma journey in The Alchemy of Cure: tinyurl.com/vmcshpr #IndiaPharmaArchives #TheAlchemyOfCure #PharmaHeritage

India is strengthening its position in the global biopharmaceutical landscape. Through the ₹10,000 crore BioPharma Shakti initiative, the government aims to accelerate biologics innovation, biosimilar development, and advanced biomanufacturing capabilities across the country. As biologic patent expiries open new opportunities and next-generation therapeutics gain momentum, the industry stands at a pivotal moment. Join IPA in association with CPI for an expert discussion on the evolving landscape of biologics, biosimilars, and mRNA therapeutics. Navigating the Future of Biologics & mRNA 📅 27 March 2026 | 🕒 15:00 IST | 💻 Virtual | Free to Attend Book your seat here: tinyurl.com/32kudtwm @ukCPI #Biologics #mRNA #Biopharma #Innovation #Webinar #LifeSciences #IPA #IndianPharma

Advanced therapies need next-generation manufacturing. How can organisations scale biologics and mRNA from lab to large-scale production? Join IPA and CPI’s webinar “Navigating the Future of Biologics & mRNA” to hear industry experts share insights on the technologies and capabilities shaping the future of advanced therapy manufacturing. 📅 27 March 2026 | 🕒 15:00 IST | 💻 Virtual | Free to Attend Book your seat here: tinyurl.com/32kudtwm @ukCPI #Biologics #mRNA #Biopharma #Innovation #Webinar #LifeSciences #IPA #IndianPharma

From Waldemar Haffkine’s pioneering vaccine work in India to today’s global leadership in vaccine manufacturing, India’s immunization journey spans more than a century of innovation. Today, India supplies 60% of the world’s vaccines, advancing the vision of 'Immunization for All.' This #NationalVaccinationDay, the Indian Pharmaceutical Alliance honours the scientists, innovators, and manufacturers making this impact possible. Explore the journey of the Indian pharmaceutical industry with The Alchemy of Cure: tinyurl.com/vmcshpr #IndiaPharmaArchives #TheAlchemyOfCure #IndianPharma #VaccineInnovation

India's biologics market is on the cusp of a major transformation — and the numbers tell the story. With over 39 high-value biologic patents expiring between 2025 and 2032, and the domestic market nearly set to double, the next phase of growth is not a distant prospect. It's already underway. But seizing this opportunity demands more than ambition. It requires the right capabilities, the right partnerships, and a clear roadmap for next-generation biomanufacturing. That's exactly what we'll be exploring at IPA and CPI's upcoming webinar - 'Navigating the Future of Biologics & mRNA' on 27 March 2026. 📅 27 March 2026 | 🕒15:00 IST | 💻 Virtual | Free to Attend 🔗 Register: tinyurl.com/32kudtwm @ukCPI #Biologics #mRNA #Biopharma #Innovation #Webinar #LifeSciences #IPA #IndianPha

India's pharmaceutical sector is at an inflexion point. Biologics and mRNA are redefining what is possible, and government-backed initiatives such as BioPharma Shakti are accelerating innovation and advanced biomanufacturing, creating undeniable momentum. Additionally, more than 39 high-value biologic patents are set to expire between 2025 and 2032, creating a generational opportunity for Indian pharma to lead the global biosimilar wave. Join the Indian Pharmaceutical Alliance (IPA) and the Centre for Process Innovation (CPI) for "Navigating the Future of Biologics and mRNA" and hear from experts on: - CPI’s biologics capabilities - from upstream and downstream development to real-world scale-up - mRNA development, manufacturing, and next-generation therapeutic modalities - Collaboration pathways to accelerate your pipeline The session will be moderated by Dr. Shridhar Narayanan, Senior Technical Advisor, IPA. Swipe to meet the speakers. 👉 📅 27 March 2026 | 🕒 15:00 IST | 💻 Virtual Mode 🔗 Register now: tinyurl.com/32kudtwm @ukCPI #Biologics #mRNA #Biopharma #Innovation #Webinar #LifeSciences #IPA #IndianPharma